Stem cell trials planned by Geron and Advanced Cell Technology have sparked concern from proponents and critics about maturity and preparedness as well as ethical aspects of the experiments. Because human trials of stem cell treatments are inevitable, companies and researchers need to be careful and make extensive preparations to ensure the safety of volunteers, said Hank Greely, a Stanford University lawyer and bioethicist.

Related Summaries